Patten Group, Inc. Merck & Co., Inc. Transaction History

Patten Group, Inc.

$441 Million
Q4 2024

A detailed history of Patten Group, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Patten Group, Inc. holds 30,377 shares of MRK stock, worth $2.77 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares

30,377

Previous 26,736 13.62%

Holding current value

$2.77 Million

Previous $3.04 Million 0.49%

% of portfolio

0.69%

Previous 0.69%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	BUY	$96.31 - $114.76 $350,664 - $417,841	3,641 Added 13.62%	30,377 $3.02 Million
Q3 2024 Oct 08, 2024	BUY	$111.15 - $128.97 $182,841 - $212,155	1,645 Added 6.56%	26,736 $3.04 Million
Q2 2024 Jul 25, 2024	BUY	$123.8 - $132.96 $3,342 - $3,589	27 Added 0.11%	25,091 $3.11 Million
Q1 2024 Apr 17, 2024	SELL	$113.24 - $131.95 $13,475 - $15,702	-119 Reduced 0.47%	25,064 $3.31 Million
Q4 2023 Jan 10, 2024	SELL	$100.18 - $109.02 $75,736 - $82,419	-756 Reduced 2.91%	25,183 $2.75 Million
Q3 2023 Oct 12, 2023	SELL	$102.95 - $114.33 $28,311 - $31,440	-275 Reduced 1.05%	25,939 $2.67 Million
Q1 2023 Apr 06, 2023	BUY	$102.94 - $114.86 $75,249 - $83,962	731 Added 2.87%	26,214 $2.79 Million
Q4 2022 Feb 10, 2023	BUY	$87.44 - $112.11 $109,912 - $140,922	1,257 Added 5.19%	25,483 $2.83 Million
Q3 2022 Oct 13, 2022	BUY	$84.53 - $94.96 $1,775 - $1,994	21 Added 0.09%	24,226 $2.12 Million
Q2 2022 Jul 18, 2022	SELL	$83.49 - $94.64 $10,352 - $11,735	-124 Reduced 0.51%	24,205 $2.25 Million
Q1 2022 Apr 28, 2022	SELL	$73.51 - $82.4 $11,026 - $12,360	-150 Reduced 0.61%	24,329 $2 Million
Q4 2021 Jan 20, 2022	SELL	$72.28 - $90.54 $243,439 - $304,938	-3,368 Reduced 12.09%	24,479 $1.88 Million
Q3 2021 Nov 15, 2021	SELL	$71.68 - $78.83 $170,168 - $187,142	-2,374 Reduced 7.86%	27,847 $2.09 Million
Q2 2021 Aug 03, 2021	SELL	$70.31 - $77.77 $65,950 - $72,948	-938 Reduced 3.01%	30,221 $2.35 Million
Q1 2021 Apr 23, 2021	SELL	$68.86 - $81.11 $23,136 - $27,252	-336 Reduced 1.07%	31,159 $2.4 Million
Q4 2020 Feb 02, 2021	BUY	$71.77 - $79.65 $285,357 - $316,688	3,976 Added 14.45%	31,495 $2.58 Million
Q3 2020 Oct 19, 2020	BUY	$73.18 - $82.95 $95,134 - $107,835	1,300 Added 4.96%	27,519 $2.18 Million
Q2 2020 Jul 20, 2020	BUY	$70.42 - $80.13 $111,263 - $126,605	1,580 Added 6.41%	26,219 $2.03 Million
Q1 2020 Apr 16, 2020	SELL	$63.36 - $87.82 $47,646 - $66,040	-752 Reduced 2.96%	24,639 $1.9 Million
Q4 2019 Jan 14, 2020	BUY	$77.58 - $87.54 $13,188 - $14,881	170 Added 0.67%	25,391 $2.31 Million
Q3 2019 Oct 22, 2019	SELL	$76.08 - $82.93 $14,911 - $16,254	-196 Reduced 0.77%	25,221 $2.12 Million
Q2 2019 Jul 11, 2019	BUY	$69.84 - $81.59 $5,307 - $6,200	76 Added 0.3%	25,417 $2.13 Million
Q1 2019 May 14, 2019	SELL	$69.58 - $79.36 $4,870 - $5,555	-70 Reduced 0.28%	25,341 $2.11 Million
Q4 2018 Feb 12, 2019	BUY	$65.24 - $75.71 $15,266 - $17,716	234 Added 0.93%	25,411 $1.94 Million
Q3 2018 Nov 14, 2018	SELL	$57.69 - $67.84 $46,613 - $54,814	-808 Reduced 3.11%	25,177 $1.79 Million
Q2 2018 Aug 14, 2018	SELL	$50.83 - $59.72 $69,687 - $81,876	-1,371 Reduced 5.01%	25,985 $1.58 Million
Q1 2018 May 11, 2018	SELL	$50.96 - $59.23 $66,044 - $76,762	-1,296 Reduced 4.52%	27,356 $1.49 Million
Q4 2017 Feb 02, 2018	SELL	$51.62 - $61.64 $299,086 - $357,142	-5,794 Reduced 16.82%	28,652 $1.61 Million
Q3 2017 Dec 13, 2017	SELL	$58.67 - $63.13 $4.66 Million - $5.01 Million	-79,403 Reduced 69.74%	34,446 $2.21 Million
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $4.65 Million - $5.01 Million	79,308 Added 229.61%	113,849 $2.21 Million
Q2 2017 Aug 14, 2017	BUY	N/A	34,541	34,541 $2.18 Million

Others Institutions Holding MRK

# of Institutions

3,956

Shares Held

1.94B

Call Options Held

16M

Put Options Held

15M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $231B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Patten Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Patten Group, Inc. with notifications on news.

Account